- ModifierDescription
- J1Competitive acquisition program no-pay submission for a prescription number
- J2Competitive acquisition program, restocking of emergency drugs after emergency administration
- J3Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology
- J4Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge
- J5Off-the-shelf orthotic subject to dmepos competitive bidding program that is furnished as part of a physical therapist or occupational therapist professional service
- JAAdministered intravenously
- JBAdministered subcutaneously
- JCSkin substitute used as a graft
- JDSkin substitute not used as a graft
- JEAdministered via dialysate
- JGDrug or biological acquired with 340b drug pricing program discount, reported for informational purposes
- JKOne month supply or less of drug or biological
- JLThree month supply of drug or biological
- JWDrug amount discarded/not administered to any patient
- JZZero drug amount discarded/not administered to any patient